CORCEPT THERAPEUTICS INC (1CORT.MI) Fundamental Analysis & Valuation

BIT:1CORT • US2183521028

Current stock price

37.59 EUR
-0.43 (-1.13%)
Last:

This 1CORT.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. 1CORT.MI Profitability Analysis

1.1 Basic Checks

  • 1CORT had positive earnings in the past year.
  • 1CORT had a positive operating cash flow in the past year.
  • In the past 5 years 1CORT has always been profitable.
  • 1CORT had a positive operating cash flow in each of the past 5 years.
1CORT.MI Yearly Net Income VS EBIT VS OCF VS FCF1CORT.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1.2 Ratios

  • With an excellent Return On Assets value of 12.88%, 1CORT belongs to the best of the industry, outperforming 84.31% of the companies in the same industry.
  • 1CORT's Return On Equity of 16.79% is fine compared to the rest of the industry. 1CORT outperforms 64.71% of its industry peers.
  • With a Return On Invested Capital value of 8.69%, 1CORT perfoms like the industry average, outperforming 54.90% of the companies in the same industry.
  • 1CORT had an Average Return On Invested Capital over the past 3 years of 17.94%. This is above the industry average of 13.61%.
  • The 3 year average ROIC (17.94%) for 1CORT is well above the current ROIC(8.69%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 12.88%
ROE 16.79%
ROIC 8.69%
ROA(3y)17.09%
ROA(5y)19.27%
ROE(3y)20.64%
ROE(5y)22.43%
ROIC(3y)17.94%
ROIC(5y)20.7%
1CORT.MI Yearly ROA, ROE, ROIC1CORT.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

1.3 Margins

  • 1CORT has a Profit Margin of 14.32%. This is in the better half of the industry: 1CORT outperforms 60.78% of its industry peers.
  • In the last couple of years the Profit Margin of 1CORT has declined.
  • With a Operating Margin value of 8.85%, 1CORT perfoms like the industry average, outperforming 45.10% of the companies in the same industry.
  • 1CORT's Operating Margin has declined in the last couple of years.
  • 1CORT has a better Gross Margin (98.19%) than 100.00% of its industry peers.
  • 1CORT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.85%
PM (TTM) 14.32%
GM 98.19%
OM growth 3Y-15.83%
OM growth 5Y-11.04%
PM growth 3Y-12.04%
PM growth 5Y-7.41%
GM growth 3Y-0.06%
GM growth 5Y0.04%
1CORT.MI Yearly Profit, Operating, Gross Margins1CORT.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. 1CORT.MI Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 1CORT is creating value.
  • Compared to 1 year ago, 1CORT has more shares outstanding
  • 1CORT has less shares outstanding than it did 5 years ago.
  • There is no outstanding debt for 1CORT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
1CORT.MI Yearly Shares Outstanding1CORT.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
1CORT.MI Yearly Total Debt VS Total Assets1CORT.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • 1CORT has an Altman-Z score of 17.35. This indicates that 1CORT is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of 1CORT (17.35) is better than 98.04% of its industry peers.
  • There is no outstanding debt for 1CORT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 17.35
ROIC/WACC0.92
WACC9.46%
1CORT.MI Yearly LT Debt VS Equity VS FCF1CORT.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 3.14 indicates that 1CORT has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 3.14, 1CORT belongs to the top of the industry, outperforming 92.16% of the companies in the same industry.
  • 1CORT has a Quick Ratio of 3.07. This indicates that 1CORT is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of 1CORT (3.07) is better than 92.16% of its industry peers.
Industry RankSector Rank
Current Ratio 3.14
Quick Ratio 3.07
1CORT.MI Yearly Current Assets VS Current Liabilites1CORT.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. 1CORT.MI Growth Analysis

3.1 Past

  • The earnings per share for 1CORT have decreased strongly by -30.16% in the last year.
  • Measured over the past years, 1CORT shows a quite strong growth in Earnings Per Share. The EPS has been growing by 9.71% on average per year.
  • The Revenue has grown by 17.92% in the past year. This is quite good.
  • 1CORT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.11% yearly.
EPS 1Y (TTM)-30.16%
EPS 3Y11.69%
EPS 5Y9.71%
EPS Q2Q%-60.98%
Revenue 1Y (TTM)17.92%
Revenue growth 3Y22.64%
Revenue growth 5Y17.11%
Sales Q2Q%13.75%

3.2 Future

  • The Earnings Per Share is expected to grow by 44.06% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, 1CORT will show a very strong growth in Revenue. The Revenue will grow by 23.55% on average per year.
EPS Next Y-23.36%
EPS Next 2Y-29.36%
EPS Next 3Y36.25%
EPS Next 5Y44.06%
Revenue Next Year17.6%
Revenue Next 2Y23.46%
Revenue Next 3Y25.84%
Revenue Next 5Y23.55%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
1CORT.MI Yearly Revenue VS Estimates1CORT.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B 2B 2.5B
1CORT.MI Yearly EPS VS Estimates1CORT.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

1

4. 1CORT.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 50.12, 1CORT can be considered very expensive at the moment.
  • 1CORT's Price/Earnings ratio is a bit more expensive when compared to the industry. 1CORT is more expensive than 62.75% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.89, 1CORT is valued quite expensively.
  • The Price/Forward Earnings ratio is 71.66, which means the current valuation is very expensive for 1CORT.
  • 66.67% of the companies in the same industry are cheaper than 1CORT, based on the Price/Forward Earnings ratio.
  • 1CORT's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 38.50.
Industry RankSector Rank
PE 50.12
Fwd PE 71.66
1CORT.MI Price Earnings VS Forward Price Earnings1CORT.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, 1CORT is valued a bit more expensive than 64.71% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, 1CORT is valued a bit more expensive than the industry average as 60.78% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 28.69
EV/EBITDA 59.4
1CORT.MI Per share data1CORT.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

  • The decent profitability rating of 1CORT may justify a higher PE ratio.
  • 1CORT's earnings are expected to grow with 36.25% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)5.16
EPS Next 2Y-29.36%
EPS Next 3Y36.25%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. 1CORT.MI Dividend Analysis

5.1 Amount

  • 1CORT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

1CORT.MI Fundamentals: All Metrics, Ratios and Statistics

CORCEPT THERAPEUTICS INC

BIT:1CORT (4/15/2026, 7:00:00 PM)

37.59

-0.43 (-1.13%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-04
Earnings (Next)02-18
Inst Owners75.42%
Inst Owner ChangeN/A
Ins Owners6.65%
Ins Owner ChangeN/A
Market Cap3.95B
Revenue(TTM)741.17M
Net Income(TTM)106.11M
Analysts75
Price Target82.87 (120.46%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)33.91%
Min EPS beat(2)16.19%
Max EPS beat(2)51.63%
EPS beat(4)3
Avg EPS beat(4)11.15%
Min EPS beat(4)-40.2%
Max EPS beat(4)51.63%
EPS beat(8)7
Avg EPS beat(8)17.67%
EPS beat(12)9
Avg EPS beat(12)13.54%
EPS beat(16)12
Avg EPS beat(16)12.14%
Revenue beat(2)0
Avg Revenue beat(2)-5.62%
Min Revenue beat(2)-6.85%
Max Revenue beat(2)-4.4%
Revenue beat(4)0
Avg Revenue beat(4)-8.72%
Min Revenue beat(4)-13.38%
Max Revenue beat(4)-4.4%
Revenue beat(8)4
Avg Revenue beat(8)-2.84%
Revenue beat(12)6
Avg Revenue beat(12)-1.77%
Revenue beat(16)7
Avg Revenue beat(16)-2.44%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)-50.34%
EPS NQ rev (3m)-50.34%
EPS NY rev (1m)-32.37%
EPS NY rev (3m)-32.37%
Revenue NQ rev (1m)-13.41%
Revenue NQ rev (3m)-13.41%
Revenue NY rev (1m)-9.38%
Revenue NY rev (3m)-9.38%
Valuation
Industry RankSector Rank
PE 50.12
Fwd PE 71.66
P/S 6.29
P/FCF 28.69
P/OCF 28.64
P/B 7.38
P/tB 7.38
EV/EBITDA 59.4
EPS(TTM)0.75
EY2%
EPS(NY)0.52
Fwd EY1.4%
FCF(TTM)1.31
FCFY3.49%
OCF(TTM)1.31
OCFY3.49%
SpS5.97
BVpS5.09
TBVpS5.09
PEG (NY)N/A
PEG (5Y)5.16
Graham Number9.26987 (-75.34%)
Profitability
Industry RankSector Rank
ROA 12.88%
ROE 16.79%
ROCE 10.07%
ROIC 8.69%
ROICexc 24.92%
ROICexgc 24.92%
OM 8.85%
PM (TTM) 14.32%
GM 98.19%
FCFM 21.93%
ROA(3y)17.09%
ROA(5y)19.27%
ROE(3y)20.64%
ROE(5y)22.43%
ROIC(3y)17.94%
ROIC(5y)20.7%
ROICexc(3y)74.13%
ROICexc(5y)85.06%
ROICexgc(3y)74.13%
ROICexgc(5y)85.06%
ROCE(3y)20.79%
ROCE(5y)23.98%
ROICexgc growth 3Y-18.86%
ROICexgc growth 5Y-17.58%
ROICexc growth 3Y-18.86%
ROICexc growth 5Y-17.58%
OM growth 3Y-15.83%
OM growth 5Y-11.04%
PM growth 3Y-12.04%
PM growth 5Y-7.41%
GM growth 3Y-0.06%
GM growth 5Y0.04%
F-Score6
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 36.2%
Cap/Sales 0.04%
Interest Coverage 250
Cash Conversion 245.43%
Profit Quality 153.21%
Current Ratio 3.14
Quick Ratio 3.07
Altman-Z 17.35
F-Score6
WACC9.46%
ROIC/WACC0.92
Cap/Depr(3y)112.18%
Cap/Depr(5y)124.4%
Cap/Sales(3y)0.15%
Cap/Sales(5y)0.19%
Profit Quality(3y)125.51%
Profit Quality(5y)133.52%
High Growth Momentum
Growth
EPS 1Y (TTM)-30.16%
EPS 3Y11.69%
EPS 5Y9.71%
EPS Q2Q%-60.98%
EPS Next Y-23.36%
EPS Next 2Y-29.36%
EPS Next 3Y36.25%
EPS Next 5Y44.06%
Revenue 1Y (TTM)17.92%
Revenue growth 3Y22.64%
Revenue growth 5Y17.11%
Sales Q2Q%13.75%
Revenue Next Year17.6%
Revenue Next 2Y23.46%
Revenue Next 3Y25.84%
Revenue Next 5Y23.55%
EBIT growth 1Y-54.26%
EBIT growth 3Y3.23%
EBIT growth 5Y4.18%
EBIT Next Year-24.4%
EBIT Next 3Y37.86%
EBIT Next 5YN/A
FCF growth 1Y5.22%
FCF growth 3Y5.38%
FCF growth 5Y7.73%
OCF growth 1Y5.34%
OCF growth 3Y5.66%
OCF growth 5Y7.79%

CORCEPT THERAPEUTICS INC / 1CORT.MI Fundamental Analysis FAQ

What is the fundamental rating for 1CORT stock?

ChartMill assigns a fundamental rating of 6 / 10 to 1CORT.MI.


What is the valuation status of CORCEPT THERAPEUTICS INC (1CORT.MI) stock?

ChartMill assigns a valuation rating of 2 / 10 to CORCEPT THERAPEUTICS INC (1CORT.MI). This can be considered as Overvalued.


How profitable is CORCEPT THERAPEUTICS INC (1CORT.MI) stock?

CORCEPT THERAPEUTICS INC (1CORT.MI) has a profitability rating of 6 / 10.


What are the PE and PB ratios of CORCEPT THERAPEUTICS INC (1CORT.MI) stock?

The Price/Earnings (PE) ratio for CORCEPT THERAPEUTICS INC (1CORT.MI) is 50.12 and the Price/Book (PB) ratio is 7.38.


What is the expected EPS growth for CORCEPT THERAPEUTICS INC (1CORT.MI) stock?

The Earnings per Share (EPS) of CORCEPT THERAPEUTICS INC (1CORT.MI) is expected to decline by -23.36% in the next year.